PARP
PARP(多聚ADP核糖聚合酶)
Poly (ADP-ribose) polymerases (PARPs) is a large family of proteins with a conserved catalytic domain that catalyze an immediate DNA-damage-dependent post-translational modification of histones and other nuclear proteins leading to the survival of injured proliferating cells. So far, a total number of 18 human PARP proteins encoded by different genes have been identified, including PARP-1 to PARP-4, PARP-5a, PARP-5b, PARP-5c and PARP-6 to PARP-16. The general structural of PARP proteins has been revealed through the extensive study of the founding family member PARP-1, which is characterized by the presence of four functional domains, including a DNA-binding domain, a caspase-cleaved domain, an automodification domain and a catalytic domain.
PARP 相关产品(120)
- GC10145PJ34 hydrochlorideCAS: 344458-15-7纯度: >99.00%
PJ34 hydrochloride是一种有效且特异性的PARP抑制剂,IC 50 值为110nM。
- GC10920BMN-673 8R,9SCAS: 1207456-00-5纯度: >98.00%
BMN-673 8R,9S ((8R,9S)-BMN-673) 是 Talazoparib 的对映异构体。 BMN-673 8R,9S 是一种 PARP1 抑制剂,IC50 为 144 nM。
- GC12422ABT-888 (Veliparib)CAS: 912444-00-9纯度: >99.50% / >98.00%
ABT-888 (Veliparib)是一种有效的PARP1和PARP2抑制剂,Ki分别为5.2和2.9nM。
- GC12756MK-4827 hydrochlorideCAS: 1038915-64-8纯度: >99.50%
MK-4827 hydrochloride (MK-4827 hydrochloride) 是一种高效且具有口服生物利用度的 PARP1 和 PARP2 抑制剂,IC50 分别为 3.8 和 2.1 nM。 MK-4827 hydrochloride 抑制 DNA 损伤的修复,激活细胞凋亡并显示出抗肿瘤活性。
- GC17580Olaparib (AZD2281, Ku-0059436)CAS: 763113-22-0纯度: >99.50% / >98.00%
Olaparib (AZD2281, Ku-0059436) 是一种有效的选择性 PARP 抑制剂,特异性靶向 PARP1 和 PARP2(IC 50 分别 = 5 nM 和 1 nM)。
- GC17783Veliparib dihydrochlorideCAS: 912445-05-7纯度: >99.50%
An orally bioavailable inhibitor of PARP1 and PARP2
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10145 | PJ34 hydrochloride | 344458-15-7 | >99.00% | |
PJ34 hydrochloride是一种有效且特异性的PARP抑制剂,IC 50 值为110nM。 | ||||
| GC10690 | BYK 204165 | 1104546-89-5 | >99.50% | |
A selective inhibitor of PARP1 | ||||
| GC10920 | BMN-673 8R,9S | 1207456-00-5 | >98.00% | |
BMN-673 8R,9S ((8R,9S)-BMN-673) 是 Talazoparib 的对映异构体。 BMN-673 8R,9S 是一种 PARP1 抑制剂,IC50 为 144 nM。 | ||||
| GC10995 | PJ34 | 344458-19-1 | >98.00% | |
PJ34是一种有效且特异性的PARP抑制剂,IC 50 值为110nM。 | ||||
| GC11537 | MK-4827 tosylate | 1038915-73-9 | >99.50% | |
An orally bioavailable PARP1/2 inhibitor | ||||
| GC11548 | Tankyrase Inhibitors (TNKS) 49 | - | - | |
Tankyrase inhibitor | ||||
| GC11674 | WIKI4 | 838818-26-1 | >99.50% | |
A potent TNKS1/2 inhibitor | ||||
| GC12390 | A-966492 | 934162-61-5 | >99.00% | |
A PARP1 and PARP2 inhibitor | ||||
| GC12422 | ABT-888 (Veliparib) | 912444-00-9 | >99.50% / >98.00% | |
ABT-888 (Veliparib)是一种有效的PARP1和PARP2抑制剂,Ki分别为5.2和2.9nM。 | ||||
| GC12496 | INO-1001 | 3544-24-9 | >99.50% | |
A PARP inhibitor | ||||
| GC12680 | DR 2313 | 284028-90-6 | >98.50% | |
A PARP inhibitor | ||||
| GC12756 | MK-4827 hydrochloride | 1038915-64-8 | >99.50% | |
MK-4827 hydrochloride (MK-4827 hydrochloride) 是一种高效且具有口服生物利用度的 PARP1 和 PARP2 抑制剂,IC50 分别为 3.8 和 2.1 nM。 MK-4827 hydrochloride 抑制 DNA 损伤的修复,激活细胞凋亡并显示出抗肿瘤活性。 | ||||
| GC12869 | JW 55 | 664993-53-7 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC12991 | EB 47 | 366454-36-6 | >99.50% | |
A PARP1 and TNKS2 inhibitor | ||||
| GC13419 | ME0328 | 1445251-22-8 | >99.50% | |
A selective PARP3 inhibitor | ||||
| GC14434 | BYK 49187 | 163120-31-8 | - | |
Potent PARP-1/PARP-2 inhibitor | ||||
| GC14509 | UPF 1069 | 1048371-03-4 | >99.00% / >98.00% | |
A selective PARP2 inhibitors | ||||
| GC15041 | Tankyrase Inhibitors (TNKS) 22 | - | - | |
Tankyrase inhibitor | ||||
| GC15353 | Iniparib (BSI-201) | 160003-66-7 | >99.50% | |
A PARP1 inhibitor | ||||
| GC16474 | 4-HQN | 491-36-1 | >99.50% | |
A heterocyclic building block | ||||
| GC17580 | Olaparib (AZD2281, Ku-0059436) | 763113-22-0 | >99.50% / >98.00% | |
Olaparib (AZD2281, Ku-0059436) 是一种有效的选择性 PARP 抑制剂,特异性靶向 PARP1 和 PARP2(IC 50 分别 = 5 nM 和 1 nM)。 | ||||
| GC17775 | NU 1025 | 90417-38-2 | >98.00% | |
An inhibitor of PARP | ||||
| GC17783 | Veliparib dihydrochloride | 912445-05-7 | >99.50% | |
An orally bioavailable inhibitor of PARP1 and PARP2 | ||||
| GC17802 | MK-4827 | 1038915-60-4 | >99.50% / >98.00% | |
MK-4827是具有口服活性的PARP抑制剂,可同时抑制PARP1(IC 50 =3.8nM)和PARP2(IC 50 =2.1nM),MK-4827可抑制PARP酶来阻断DNA修复,诱导癌细胞死亡。 | ||||
